Business
Press Release Dec 01 2023
Syngene International Limited has informed the Exchange regarding a press release dated December 01, 2023, titled "Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd".
About this update from Syngene International Ltd.
[{"type":"text","content":" Syngene International Limited has informed the Exchange regarding a press release dated December 01, 2023, titled \"Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd\". View Attachment","length":364,"tagName":"div"}]